[79] Cenac N, Chin AC,

Garcia-Villar R, Salvador-Cartier C, Ferrier L, Vergnolle N, et al. PAR-2 activation alters colonic paracellular permeability in mice via IFN-gammadependent and -independent pathways. The Journal of Physiology. 2004;**558** (Pt 3):913-925

[80] Reed DE, Barajas-Lopez C, Cottrell G, Velazquez-Rocha S, Dery O, Grady EF, et al. Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons. The Journal of Physiology. 2003;**547**(Pt 2):531-542

[81] Du L, Long Y, Kim JJ, Chen B, Zhu Y, Dai N. Protease activated Receptor-2 induces immune activation and visceral hypersensitivity in postinfectious irritable bowel syndrome mice. Digestive Diseases and Sciences. 2018;**64**(3):729-739

[82] Shi HL, Liu CH, Ding LL, Zheng Y, Fei XY, Lu L, et al. Alterations in serotonin, transient receptor potential channels and proteaseactivated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction. World Journal of Gastroenterology. 2015;**21**(16):4852-4863

[83] Cenac N, Andrews CN, Holzhausen M, Chapman K, Cottrell G, Andrade-Gordon P, et al. Role for protease activity in visceral pain in irritable bowel syndrome. The Journal of Clinical Investigation. 2007;**117**(3):636-647

[84] Gecse K, Róka R, Ferrier L, Leveque M, Eutamene H, Cartier C, et al. Increased faecal serine protease activity in diarrhoeic IBS patients: A colonic lumenal factor impairing colonic permeability and sensitivity. Gut. 2008;**57**(5):591-599

[85] Annahazi A, Gecse K, Dabek M, Ait-Belgnaoui A, Rosztoczy A, Roka R, et al. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice. Pain. 2009;**144**(1-2):209-217

[86] Tooth D, Garsed K, Singh G, Marciani L, Lam C, Fordham I, et al. Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: Origin and effect of gut transit. Gut. 2014;**63**(5):753-760

[87] Vergnolle N, Wallace JL, Bunnett NW, Hollenberg MD. Proteaseactivated receptors in inflammation, neuronal signaling and pain. Trends in Pharmacological Sciences. 2001;**22**(3):146-152

[88] Kawabata A, Kawao N, Kitano T, Matsunami M, Satoh R, Ishiki T, et al. Colonic hyperalgesia triggered by proteinase-activated receptor-2 in mice: Involvement of endogenous bradykinin. Neuroscience Letters. 2006;**402**(1-2):167-172

[89] Valdez-Morales EE, Overington J, Guerrero-Alba R, Ochoa-Cortes F, Ibeakanma CO, Spreadbury I, et al. Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: A role for PAR2. The American Journal of Gastroenterology. 2013;**108**(10):1634-1643

[90] Xu W, Yuan M, Wu X, Geng H, Chen L, Zhou J, et al. Electroacupuncture relieves visceral hypersensitivity by inactivating protease-activated receptor 2 in a rat model of postinfectious irritable bowel syndrome. Evidencebased Complementary and Alternative Medicine. 2018:7048584

[91] Clark AK, Yip PK, Malcangio M. The liberation of fractalkine in the dorsal horn requires microglial cathepsin S. The Journal of Neuroscience. 2009;**29**(21):6945-6954

[92] Cattaruzza F, Lyo V, Jones E, Pham D, Hawkins J, Kirkwood K, et al. Cathepsin S is activated during colitis and causes visceral hyperalgesia by a PAR 2-dependent mechanism in mice. Gastroenterology. 2011;**141**(5):1864-1874

[93] Fiorucci S, Distrutti E. Role of PAR2 in pain and inflammation. Trends in Pharmacological Sciences. 2002;**23**(4):153-155

[94] Hoogerwerf WA, Zou L, Shenoy M, Sun D, Micci MA, Lee-Hellmich H, et al. The proteinase-activated receptor 2 is involved in nociception. The Journal of Neuroscience. 2001;**21**(22):9036-9042

[95] Hoogerwerf WA, Shenoy M, Winston JH, Xiao SY, He Z, Pasricha PJ. Trypsin mediates nociception via the proteinase-activated receptor 2: A potentially novel role in pancreatic pain. Gastroenterology. 2004;**127**(3):883-891

[96] Wang P, Chen FX, Du C, Li CQ, Yu YB, Zuo XL, et al. Increased production of BDNF in colonic epithelial cells induced by fecal supernatants from diarrheic IBS patients. Scientific Reports. 2015;**5**:10121

*Intervention of PAR-2 Mediated CGRP in Animal Model of Visceral Hyperalgesia DOI: http://dx.doi.org/10.5772/intechopen.106859*

[97] Delafoy L, Gelot A, Ardid D, Eschalier A, Bertrand C, Doherty AM, et al. Interactive involvement of brain derived neurotrophic factor, nerve growth factor, and calcitonin gene related peptide in colonic hypersensitivity in the rat. Gut. 2006;**55**(7):940-945

[98] Thompson BJ, Washington MK, Kurre U, Singh M, Rula EY, Emeson RB. Protective roles of alpha-calcitonin and beta-calcitonin gene-related peptide in spontaneous and experimentally induced colitis. Digestive Diseases and Sciences. 2008;**53**(1):229-241

[99] Julia V, Bueno L. Tachykininergic mediation of viscerosensitive responses to acute inflammation in rats: Role of CGRP. The American Journal of Physiology. 1997;**272**(1 Pt 1):G141-G146

[100] Deng D-X, Tan J, Zhang H, Huang G-L, Li S, Guo K-K, et al. Electroacupuncture relieves visceral hypersensitivity by down-regulating mast cell number PAR-2/TRPV 1 signaling, etc. in colonic tissue of rats with irritable bowel syndrome. Acupuncture Research. 2018;**43**(8):485-491

[101] Noor-Mohammadi E, Ligon CO, Mackenzie K, Stratton J, Shnider S, Greenwood-Van MB. A Monoclonal Anti–Calcitonin gene-related peptide antibody decreases stress-induced colonic hypersensitivity. The Journal of Pharmacology and Experimental Therapeutics. 2021;**379**(3):270-279

[102] Zhang L, Song J, Hou X. Mast cells and irritable bowel syndrome: From the bench to the bedside. Journal of Neurogastroenterology and Motility. 2016;**22**(2):181-192

[103] Qiao LY, Grider JR. Colitis induces calcitonin gene-related peptide expression and Akt activation in rat primary afferent pathways. Experimental Neurology. 2009;**219**(1):93-103

Section 2
